Markets Pty Ltd News Today

Canadian psychedelics biotech Tryp Therapeutics Inc. has entered into an agreement with Australian publicly-trading drug vehicle developer Exopharm Ltd. for the acquisition of 100% of Tryp’s issued and outstanding common shares. 

Tryp Therapeutics Announces Closing of Oversubscribed Private Placement ...

To go to market expansion, product development, customer experience, operational efficiency, partnerships and AI.

Bringing Taiwan to the World and the World to Taiwan

Tamboran Resources Limited (ASX:TBN) (OTCMKTS:TBNNY) has received binding commitments for a non-underwritten placement to new and existing shareholders to raise up to ~$53.2 million at $0.18 per share.